Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Back in the fives after a two day beat down.
Definitely buying tomorrow.
A circular meeting is my guess.
The like button was very useful in elevating good posts but now there are all these stupid emojis that I can't half make out what they mean.
I would say A-371's trial design would have began soon after the Aug 7 journal press release confirming Anavex 3-71's cardiovascular safety,. These data also expand the safety objectives met in this first-in-human study of Anavex3-71, further supporting its drug development program. This has been ongoing from inception so nothing pivotal about it.
Yes those are the facts anything contrary is just noise.
George doesn't bother me but I'm not short either.
Being short keeps one up at night it seems. Not healthy
Possibly some short will to try and use it to their advantage.. We need the full AD scientific journal report for all to see plus an NDA update.
"BeaMed is on track to submit, in Q2 2024, the System for potential FDA approval via the 510(k) regulatory pathway." 5 months since last update. Ok Leo time to wake up.
So basically your another concerned short. Got it.
Naw just a warmed over old short.
A little over 2 grand traded, not much to split between all of them. Looks like it's beans again.
Shorts positions demolished.
Doc Missling reported patients on A-273 for 5 years. The only doc that matters.
By others you mean the mabs lol. EU said pass on those for good reason. I now actually think EMA is the more friendly route then the FDA.
No. I am firmly long here and sleep well at night.
FDA would no doubt take in account positive RWE outcomes when weighing approval. 93% wanting to remain on A-273, Canada allowing compassionate use for patients to remain on A-273. A-273 reported good safety outcomes the alternative largely has terrible side effects.
90% huh, guess you should add your name to that list.
You set over this board either like a hawk or a buzzard take your pick.
They could appeal the ruling and buy some time. Need to hear something from Leo. I don't think Leo has a very strong case though. He should have been more diligent.
They are busy flipping the stock for nickles. It's a lot of work.
Yep things can happen quickly. Thanks.
First off it needs to be something negative.
I hear ya. Go 2024
You wanting back in?
Nice accumulation again, so do we have a group getting in before boom
Nice follow through today!
Also our BeaMed investment.
Being short is stressful.
Phase 2b/3 12/01/22 press release still stands- ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS,
SHOWING STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN GLOBAL CLINICAL STUDY OF PATIENTS WITH EARLY ALZHEIMER’S DISEASE
The approved mab saw amyloid plaque reduction but also had SAE's brain bleeds even death. Blarcamesine reported to not only reduce amyloid plaques safely, patients also found to have a reduction in brain volume loss. Reduction in brain loss is a huge finding.
Reducing plaques is a marker but still the standard in the archaic FDA.
WGT
He retired so he maybe in Florida enjoying the warmer weather.
Out of that 15% failure rate how many were weeded out early rather then later. I would think your approval chances would improve the longer you remain in the process.
I figured he worked for Biogen.
Was just a thought. Anyway Biogen's mab sales will likely falter once Blarcamesine is approved.
Nice move up!
Do the right thing and stop cluttering up the board.
A few years ago a banker. Today a CNS expert quite the leap.
It's perspective. I actually like the buying opportunity.
Replay- A-371 found to also have M1 activity. An M1 agonist was recently bought by Bristol Meyers for $14 Bllion.
Missling even said there are patients who have been on A-273 for five years. Made me think of the Ern Heaven video.
https://video.search.yahoo.com/search/video?fr=yfp-t-s&ei=UTF-8&p=ern+heaven+video+youtube#id=1&vid=6978632570536748c61756b71eb75b23&action=click
Something new would require a press release. Could come at the last minute but we'll see.